Skip to main content
Quest Diagnostics

Individual and Community Factors Associated With Detectable and Elevated Blood Lead in US Children: Results From a National Clinical Laboratory

PriMed 2021
Boston, MA, December 9-11, 2021

Poster presentation: Individual and Community Factors Associated With Detectable and Elevated Blood Lead in US Children: Results From a National Clinical Laboratory

Authors: Hauptman M, Niles JK, Gudin J, Kaufman HW

Specialties: Prescription Drug Monitoring, Toxicology, Pediatrics

Related content

Publication
Individual and Community-Level Factors Associated With Detectable and Elevated Blood Lead Levels in US Children: Results From a National Clinical Laboratory
Publication
Early Detection in Childhood Lead Exposure Relies on Timely Testing-Reply
Publication
Impact of the COVID-19 Pandemic on Blood Lead Testing in Children in the United States

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2025 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.